Skip to main content
Journal cover image

Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial.

Publication ,  Journal Article
Felker, GM; North, R; Mulder, H; Jones, WS; Anstrom, KJ; Patel, MJ; Butler, J; Ezekowitz, JA; Lam, CSP; O'Connor, CM; Roessig, L ...
Published in: J Card Fail
August 2023

BACKGROUND: Hospitalization due to heart failure (HFH) is a major source of morbidity, consumes significant economic resources and is a key endpoint in HF clinical trials. HFH events vary in severity and implications, but they are typically considered equivalent when analyzing clinical trial outcomes. OBJECTIVES: We aimed to evaluate the frequency and severity of HF events, assess treatment effects and describe differences in outcomes by type of HF event in VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction). METHODS: VICTORIA compared vericiguat with placebo in patients with HF with reduced ejection fraction (< 45%) and a recent worsening HF event. All HFHs were prospectively adjudicated by an independent clinical events committee (CEC) whose members were blinded to treatment assignment. We evaluated the frequency and clinical impact of HF events by severity, categorized by highest intensity of HF treatment (urgent outpatient visit or hospitalization treated with oral diuretics, intravenous diuretics, intravenous vasodilators, intravenous inotropes, or mechanical support) and treatment effect by event categories. RESULTS: In VICTORIA, 2948 HF events occurred in 5050 enrolled patients. Overall total CEC HF events for vericiguat vs placebo were 43.9 vs 49.1 events/100 patient-years (P = 0.01). Hospitalization for intravenous diuretics was the most common type of HFH event (54%). HF event types differed markedly in their clinical implications for both in-hospital and post-discharge events. We observed no difference in the distribution of HF events between randomized treatment groups (P = 0.78). CONCLUSION: HF events in large global trials vary significantly in severity and clinical implications, which may have implications for more nuanced trial design and interpretation. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov (NCT02861534).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Card Fail

DOI

EISSN

1532-8414

Publication Date

August 2023

Volume

29

Issue

8

Start / End Page

1113 / 1120

Location

United States

Related Subject Headings

  • Ventricular Dysfunction, Left
  • Treatment Outcome
  • Stroke Volume
  • Patient Discharge
  • Humans
  • Heart Failure
  • Cardiovascular System & Hematology
  • Aftercare
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Felker, G. M., North, R., Mulder, H., Jones, W. S., Anstrom, K. J., Patel, M. J., … VICTORIA Study Group, . (2023). Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial. J Card Fail, 29(8), 1113–1120. https://doi.org/10.1016/j.cardfail.2023.04.015
Felker, G Michael, Rebecca North, Hillary Mulder, W Schuyler Jones, Kevin J. Anstrom, Mahesh J. Patel, Javed Butler, et al. “Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial.J Card Fail 29, no. 8 (August 2023): 1113–20. https://doi.org/10.1016/j.cardfail.2023.04.015.
Felker GM, North R, Mulder H, Jones WS, Anstrom KJ, Patel MJ, et al. Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial. J Card Fail. 2023 Aug;29(8):1113–20.
Felker, G. Michael, et al. “Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial.J Card Fail, vol. 29, no. 8, Aug. 2023, pp. 1113–20. Pubmed, doi:10.1016/j.cardfail.2023.04.015.
Felker GM, North R, Mulder H, Jones WS, Anstrom KJ, Patel MJ, Butler J, Ezekowitz JA, Lam CSP, O’Connor CM, Roessig L, Hernandez AF, Armstrong PW, VICTORIA Study Group. Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial. J Card Fail. 2023 Aug;29(8):1113–1120.
Journal cover image

Published In

J Card Fail

DOI

EISSN

1532-8414

Publication Date

August 2023

Volume

29

Issue

8

Start / End Page

1113 / 1120

Location

United States

Related Subject Headings

  • Ventricular Dysfunction, Left
  • Treatment Outcome
  • Stroke Volume
  • Patient Discharge
  • Humans
  • Heart Failure
  • Cardiovascular System & Hematology
  • Aftercare
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology